Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 17 | 2022 | 3022 | 1.180 |
Why?
|
| Quality Assurance, Health Care | 5 | 2014 | 225 | 1.010 |
Why?
|
| Accreditation | 3 | 2014 | 61 | 0.870 |
Why?
|
| Cancer Care Facilities | 2 | 2014 | 30 | 0.770 |
Why?
|
| Carcinoma, Ductal, Breast | 5 | 2014 | 160 | 0.700 |
Why?
|
| Carcinoma, Lobular | 4 | 2014 | 81 | 0.640 |
Why?
|
| Registries | 5 | 2015 | 808 | 0.640 |
Why?
|
| Mastectomy, Segmental | 2 | 2010 | 101 | 0.600 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 149 | 0.540 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2014 | 117 | 0.530 |
Why?
|
| Data Collection | 4 | 2015 | 377 | 0.520 |
Why?
|
| Rectal Neoplasms | 3 | 2014 | 129 | 0.510 |
Why?
|
| General Surgery | 5 | 2010 | 236 | 0.510 |
Why?
|
| Surgeons | 4 | 2022 | 249 | 0.500 |
Why?
|
| Medical Oncology | 4 | 2010 | 384 | 0.470 |
Why?
|
| Population Surveillance | 3 | 2011 | 216 | 0.460 |
Why?
|
| Databases, Factual | 8 | 2016 | 866 | 0.450 |
Why?
|
| Patient Care | 2 | 2014 | 102 | 0.440 |
Why?
|
| Mastectomy | 5 | 2022 | 246 | 0.410 |
Why?
|
| Patient Care Team | 1 | 2014 | 284 | 0.390 |
Why?
|
| United States | 16 | 2016 | 7114 | 0.380 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 13 | 0.370 |
Why?
|
| Neoplasms | 6 | 2014 | 3067 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 1355 | 0.340 |
Why?
|
| Breast Diseases | 1 | 2010 | 100 | 0.340 |
Why?
|
| Hospitals | 3 | 2018 | 303 | 0.340 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 376 | 0.270 |
Why?
|
| Global Health | 1 | 2008 | 193 | 0.270 |
Why?
|
| Mammaplasty | 2 | 2022 | 110 | 0.270 |
Why?
|
| Ergonomics | 3 | 2022 | 23 | 0.260 |
Why?
|
| Female | 20 | 2022 | 46602 | 0.210 |
Why?
|
| Brachytherapy | 2 | 2014 | 120 | 0.210 |
Why?
|
| Humans | 28 | 2022 | 89985 | 0.210 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2022 | 8 | 0.200 |
Why?
|
| Neoplasm Staging | 7 | 2018 | 2000 | 0.200 |
Why?
|
| Mammography | 2 | 2011 | 475 | 0.190 |
Why?
|
| Quality Improvement | 2 | 2015 | 457 | 0.180 |
Why?
|
| Specialty Boards | 1 | 1999 | 24 | 0.170 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2018 | 73 | 0.170 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 46 | 0.160 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 6785 | 0.160 |
Why?
|
| Sentinel Lymph Node | 1 | 2018 | 17 | 0.160 |
Why?
|
| Interdisciplinary Communication | 2 | 2010 | 131 | 0.160 |
Why?
|
| Nipples | 3 | 2022 | 37 | 0.140 |
Why?
|
| Societies, Medical | 3 | 2014 | 584 | 0.130 |
Why?
|
| Breast | 1 | 1998 | 292 | 0.130 |
Why?
|
| Quality Control | 2 | 2015 | 117 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 15 | 0.120 |
Why?
|
| Prognosis | 5 | 2019 | 3800 | 0.120 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 30 | 0.120 |
Why?
|
| Clinical Coding | 1 | 2015 | 24 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 69 | 0.120 |
Why?
|
| Medical Records | 1 | 2015 | 120 | 0.120 |
Why?
|
| Biopsy | 1 | 1998 | 1184 | 0.110 |
Why?
|
| Aged | 10 | 2018 | 19262 | 0.110 |
Why?
|
| Leadership | 1 | 2014 | 141 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 148 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 3678 | 0.100 |
Why?
|
| Middle Aged | 10 | 2019 | 26159 | 0.100 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2013 | 173 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 471 | 0.100 |
Why?
|
| Workload | 2 | 2022 | 129 | 0.090 |
Why?
|
| Operating Rooms | 2 | 2022 | 125 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 598 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 682 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 45 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2010 | 315 | 0.080 |
Why?
|
| Total Quality Management | 1 | 2008 | 33 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 569 | 0.080 |
Why?
|
| Program Development | 1 | 2008 | 127 | 0.070 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2007 | 36 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 432 | 0.070 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2007 | 72 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2007 | 66 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2008 | 312 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2007 | 145 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2007 | 290 | 0.070 |
Why?
|
| American Cancer Society | 2 | 2004 | 13 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2657 | 0.070 |
Why?
|
| Axilla | 2 | 2018 | 103 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2007 | 476 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 4329 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2007 | 234 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 848 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 1169 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1704 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2007 | 550 | 0.050 |
Why?
|
| Adult | 6 | 2016 | 26827 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2014 | 8277 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2014 | 468 | 0.050 |
Why?
|
| Health Policy | 1 | 2004 | 188 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 5358 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1214 | 0.040 |
Why?
|
| Male | 4 | 2016 | 42690 | 0.040 |
Why?
|
| SEER Program | 2 | 2000 | 205 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2000 | 94 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 6415 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 135 | 0.040 |
Why?
|
| Information Systems | 1 | 1997 | 29 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 872 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 495 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 572 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 376 | 0.030 |
Why?
|
| Age Factors | 2 | 2012 | 1880 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 220 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 281 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 596 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 604 | 0.020 |
Why?
|
| Postmenopause | 1 | 2009 | 102 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1997 | 1747 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 1497 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 2370 | 0.010 |
Why?
|
| Information Services | 1 | 2000 | 23 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 2000 | 32 | 0.010 |
Why?
|
| Mastectomy, Radical | 1 | 1997 | 10 | 0.010 |
Why?
|
| Spain | 1 | 1997 | 32 | 0.010 |
Why?
|
| Indians, North American | 1 | 1997 | 47 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1997 | 125 | 0.010 |
Why?
|
| Educational Status | 1 | 1995 | 195 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 1075 | 0.010 |
Why?
|